283 related articles for article (PubMed ID: 32152465)
1. Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.
Chen SY; Yang Y; Qi SN; Wang Y; Hu C; He X; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Qiao XY; Wang H; Li GF; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Wu T; Zhu SY; Shi M; Xu LM; Yuan ZY; Yahalom J; Tsang R; Song YQ; Zhu J; Su H; Li YX
Leukemia; 2021 Jan; 35(1):130-142. PubMed ID: 32152465
[TBL] [Abstract][Full Text] [Related]
2. A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphoma.
Liu X; Liang Y; Shen Z; Wei L; Yang J; Piao Y; Sang W; Li P; Wang L
Cancer Med; 2023 May; 12(9):10660-10671. PubMed ID: 36924334
[TBL] [Abstract][Full Text] [Related]
3. Nomograms based on SUVmax of
Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
[TBL] [Abstract][Full Text] [Related]
4. Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study.
Yang Y; Zhang YJ; Zhu Y; Cao JZ; Yuan ZY; Xu LM; Wu JX; Wang W; Wu T; Lu B; Zhu SY; Qian LT; Zhang FQ; Hou XR; Liu QF; Li YX
Leukemia; 2015 Jul; 29(7):1571-7. PubMed ID: 25697894
[TBL] [Abstract][Full Text] [Related]
5. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Nomogram for Overall Survival in Early Stage Extranodal Natural Killer/T Cell Lymphoma Treated With High-Dose Radiotherapy.
Huang L; Wu Y; Wang Y; Xie Y; Wu F; Li S; Liang Z; Zhu X
Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):289-295. PubMed ID: 32122775
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients.
Li K; Wang R; Huang S; Pan X; Chen H; Zhou L; Wei J; Wu C; Zhu X; Liang S; Qu S
Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):e537-e543. PubMed ID: 30243570
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of controlling nutritional status (CONUT) score-based nomogram on extranodal natural killer/T cell lymphoma patients.
Zhang S; Sun C; Chen X; Li D; Hu L; Zhang M; Zhang X; Zhang H; Ye J; Wang L; Jia T; Zhu T; Miao Y; Wang C; Wang L; Yan D; Shen Z; Sang W
Ann Hematol; 2023 Jun; 102(6):1433-1442. PubMed ID: 37074377
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification and prognostic value of multi-modal MRI-based radiomics for extranodal nasal-type NK/T-cell lymphoma.
Zhao YT; Chen SY; Liu X; Yang Y; Chen B; Song YW; Fang H; Jin J; Liu YP; Jing H; Tang Y; Li N; Lu NN; Wang SL; Ouyang H; Hu C; Liu J; Wang Z; Chen F; Yin L; Zhong QZ; Men K; Dai JR; Qi SN; Li YX
BMC Cancer; 2023 Jan; 23(1):88. PubMed ID: 36698118
[TBL] [Abstract][Full Text] [Related]
10. Impact of the peripheral blood inflammatory indices and modified nomogram-revised risk index on survival of Extranodal Nasal-Type Natural Killer/T-Cell lymphoma.
Hou Q; Li H; Liang Y; Yao N; Cao X; Liu J; Sun B; Feng P; Zhang W; Cao J
Cancer Biomark; 2024; 39(1):27-36. PubMed ID: 37522199
[TBL] [Abstract][Full Text] [Related]
11. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
Kim SJ; Yoon DH; Jaccard A; Chng WJ; Lim ST; Hong H; Park Y; Chang KM; Maeda Y; Ishida F; Shin DY; Kim JS; Jeong SH; Yang DH; Jo JC; Lee GW; Choi CW; Lee WS; Chen TY; Kim K; Jung SH; Murayama T; Oki Y; Advani R; d'Amore F; Schmitz N; Suh C; Suzuki R; Kwong YL; Lin TY; Kim WS
Lancet Oncol; 2016 Mar; 17(3):389-400. PubMed ID: 26873565
[TBL] [Abstract][Full Text] [Related]
12. A Nomogram Model Based on the Inflammation-Immunity-Nutrition Score (IINS) and Classic Clinical Indicators for Predicting Prognosis in Extranodal Natural Killer/T-Cell Lymphoma.
He Y; Luo Z; Chen H; Ping L; Huang C; Gao Y; Huang H
J Inflamm Res; 2024; 17():2089-2102. PubMed ID: 38595337
[TBL] [Abstract][Full Text] [Related]
13. Extranodal NK/T-cell lymphoma, nasal type: Clinical features, outcome, and prognostic factors in 101 cases.
Su YJ; Wang PN; Chang H; Shih LY; Lin TL; Kuo MC; Chuang WY; Wu JH; Tang TC; Hung YS; Dunn P; Kao HW
Eur J Haematol; 2018 Sep; 101(3):379-388. PubMed ID: 29908084
[TBL] [Abstract][Full Text] [Related]
14. Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study.
Wei YC; Liu WX; Qi F; Zhang CG; Zheng BM; Xie Y; Chen B; Zhang D; Liu WP; Fang H; Chai Y; Qi SN; Li YX; Wang WH; Song YQ; Zhu J; Dong M
Ann Hematol; 2024 Jan; 103(1):163-174. PubMed ID: 37817010
[TBL] [Abstract][Full Text] [Related]
15. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin level, a prognostic factor for nasal extranodal natural killer/T-cell lymphoma patients from stage I to IV: A validated prognostic nomogram.
Cao J; Lan S; Shen L; Si H; Xiao H; Yuan Q; Li X; Li H; Guo R
Sci Rep; 2017 Sep; 7(1):10982. PubMed ID: 28887511
[TBL] [Abstract][Full Text] [Related]
17. A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.
Wang L; Xia ZJ; Lu Y; Wang QX; Niu SQ; Huang HQ; Zhang YJ
Leuk Lymphoma; 2015; 56(11):3038-44. PubMed ID: 25747971
[TBL] [Abstract][Full Text] [Related]
18. Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study.
Qi SN; Yang Y; Zhang YJ; Huang HQ; Wang Y; He X; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Qiao XY; Wang H; Li GF; Zhu Y; Cao JZ; Wu JX; Wu T; Zhu SY; Shi M; Xu LM; Yuan ZY; Su H; Song YQ; Zhu J; Hu C; Li YX
Am J Hematol; 2020 Sep; 95(9):1047-1056. PubMed ID: 32449800
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.
Xu PP; Wang Y; Shen Y; Wang L; Shen ZX; Zhao WL
Med Oncol; 2012 Sep; 29(3):2176-82. PubMed ID: 21710236
[TBL] [Abstract][Full Text] [Related]
20. Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type.
Li YJ; Yi PY; Li JW; Liu XL; Liu XY; Zhou F; OuYang Z; Sun ZY; Huang LJ; He JQ; Yao Y; Fan Z; Tang T; Jiang WQ
Oncotarget; 2017 Jan; 8(3):4245-4256. PubMed ID: 28002803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]